Nasdaq IPOs

nCino, which offers cloud-based software for financial institutions, announced terms for its IPO on Monday. The Wilmington, NC-based company plans to raise $175 million by offering 7.6 million shares at a price range of $22 to $24. At the midpoint of the proposed range, nCino wou

AlloVir, a Phase 2 biotech developing allogeneic T cell therapies for viral diseases, filed on Monday with the SEC to raise up to $100 million in an initial public offering. The company's pipeline contains lead candidate Viralym-M, a multi-virus-specific T cel

Inventiva, a Phase 2 French biotech developing therapies for NASH and other diseases, announced terms for its IPO on Monday. The Daix, France-based company plans to raise $102 million by offering 7.5 million ADSs at $13.68, the as-converted last close of its shares on the Euronex

Poseida Therapeutics, a Phase 2 biotech developing CAR T cell therapies for multiple myeloma, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the midpoint of the pr

Vasta Platform, a K-12 educational technology provider in Brazil being spun out of Cogna, filed on Monday with the SEC to raise up to $100 million in an initial public offering. The company has developed a "Platform as a Service" with two main modules: its Content & EdTe

Following the long weekend, two Chinese IPOs and a preclinical biotch are currently scheduled to list in the US in the week ahead: China’s largest LGBTQ dating app BlueCity (BLCT), on-demand worker platform Quhuo (QH), and preclinical oncology biotech Nkarta (NKTX) More dea

Three IPOs raised $2.3 billion this past week, led by Dun & Bradstreet's (DNB) billion-dollar deal. All three IPOs upsized their deals and priced above the range. Commercial data analytics provider Dun & Bradstreet (DNB) raised $1.7 billion at a $9 billion market cap. Th

East Resources Acquisition, a blank check company formed by Terrence Pegula targeting the North American energy industry, filed on Thursday with the SEC to raise up to $300 million in an initial public offering. The Boca Raton, FL-based company plans to raise $300 million by offe

PaxMedica, a Phase 2 biotech developing therapies for neurodevelopmental disorders, filed on Thursday with the SEC to raise up to $17 million in an initial public offering. The company's lead candidate PAX-101, an intravenous formulation of suramin, is currently in a Phase 2B cli

PaxMedica, a Phase 2 biotech developing therapies for neurodevelopmental disorders, filed on Thursday with the SEC to raise up to $17 million in an initial public offering. The company's lead candidate PAX-101, an intravenous formulation of suramin, is currently in a Phase 2B cli

Nkarta, a preclinical developer of off-the-shelf cancer therapies based on natural killer cells, announced terms for its IPO on Thursday. The South San Francisco, CA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the mid

Sun BioPharma, a clinical-stage biotech developing small molecule therapies for pancreatic cancer, filed on Thursday with the SEC to raise up to $12 million in an initial public offering. The company is currently listed on the OTCQB (SNBP) and has a market cap of $42 million. The

CN Energy, which produces wood-based activated carbon and biomass energy, filed on Thursday with the SEC to raise up to $23 million in an initial public offering. The Hangzhou, China-based company plans to raise $23 million by offering 5 million shares at a price range of $4 to $

Inozyme Pharma, a preclinical biotech developing therapies for diseases of abnormal mineralization, filed on Thursday with the SEC to raise up to $86 million in an initial public offering. The company's lead candidate, INZ-701, is a soluble, genetically engineered fusio

Vertex, which provides comprehensive tax software for businesses, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. Vertex delivers comprehensive tax solutions and derives its revenue from software subscriptions and services. It automa

In the first six months of the year, Nasdaq welcomed 69 IPOs, raising $17.4 billion, outpacing the New York Stock Exchange.

Ascendant Digital Acquisition, a blank check company targeting an interactive digital entertainment business, filed on Thursday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 millio

Property Solutions Acquisition, a blank check company formed by Benchmark Real Estate Group targeting the real estate industry, filed on Thursday with the SEC to raise up to $200 million in an initial public offering. The New York, NY-based company plans to raise $200 million by

Capstar Special Purpose Acquisition, a blank check company formed by investment firm Capstar Partners, raised $240 million by offering 24 million units at $10. The company offered 4 million more units than anticipated. Each unit consists of one share of common stock and one-half

Accolade, which provides a healthcare benefits management platform for self-insured employers, raised $220 million by offering 10 million shares at $22, above the range of $19 to $21. The company offered 1.3 million more shares than anticipated. At pricing, the company commands a